The effect of a new specificΞ±-amylase in
β
H. G. Eichler; A. Korn; S. Gasic; W. Pirson; J. Businger
π
Article
π
1984
π
Springer
π
English
β 324 KB
Trestatin (Ro 9-0154), a new specific alpha-amylase inhibitor of microbial origin, was tested in six normal subjects and seven Type 2 (non-insulin-dependent) diabetic patients. In normal subjects the maximal increases in blood glucose following a 115-g starch meal were 2.19 +/- 0.57 mmol/l (mean +/-